Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daily vs Alternate Day Iron Supplementation in Children with IDA
NCT06631612Phase 4Active, not recruiting
- Sponsor
- Ain Shams University
- Start
- Jan 2024
- Primary completion
- Jan 2025
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of iron polymaltose in iron deficiency anemia (IDA) (2 arms), sponsored by Ain Shams University. Primary endpoints: Change in Hemoglobin at 8 weeks and Change in Iron Profile at 8 weeks. Started Jan 2024; status: active, not recruiting.
02
Drugs
iron polymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT06631612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06631612.